DEGRADANT COMPOUND IN A MEDICAMENT

63/162,367 | U.S. Patent Application

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Location ELECTRONIC
Filed March 17, 2021
Case Type Provisional
Status Provisional Application Expired
Child PCT/US21/57720 Published
Child 18/250,921 Pending
Child 18/535,520 Pending
Last Updated: 1 year, 2 months ago
Date # Transaction
3/20/2022EXPIRED PROVISIONAL
10/5/2021Communication - Re: Power of Attorney (PTOL-308) Office Actions Communications
10/5/2021Email Notification
10/5/2021Change in Power of Attorney (May Include Associate POA)
10/4/2021Correspondence Address Change
9/30/2021Power of Attorney Written Arguments, Opinions, Incoming amendments, Papers received from applicants
9/30/2021Electronic Filing System Acknowledgment Receipt Office Actions Communications
3/25/2021Filing Receipt
3/25/2021Email Notification
3/25/2021Application ready for PDX access by participating foreign offices
3/25/2021Application Is Now Complete
3/25/2021Filing Receipt
3/24/2021Application Dispatched from OIPE
3/24/2021Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27
3/17/2021Specification Application Documents
3/17/2021Claims Application Documents
3/17/2021Fee Worksheet (SB06) In-house documents including Examiner Notes/Search Results
3/17/2021Electronic Filing System Acknowledgment Receipt Office Actions Communications
3/17/2021PTO/SB/69-Authorize EPO Access to Search Results
3/17/2021Applicants have given acceptable permission for participating foreign
3/17/2021Entity Status Set To Undiscounted (Initial Default Setting or Status Change)
3/17/2021Initial Exam Team nn